The MMSE and MoCA for Screening Cognitive Impairment in Less Educated Patients with Parkinson's Disease by �넀�쁺�샇 & �씠�븘�쑕
152  Copyright © 2016 The Korean Movement Disorder Society
The MMSE and MoCA for Screening Cognitive 
Impairment in Less Educated Patients  
with Parkinson’s Disease
Ji In Kim,1 Mun Kyung Sunwoo,2 Young H. Sohn,3 Phil Hyu Lee,3,4 Jin Y. Hong1
1Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea
2Department of Neurology, Bundang Jesaeng General Hospital, Seongnam, Korea
3Department of Neurology and Brain Research Institute, Yonsei University College of Medicine, Seoul, Korea
4Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea
ABSTRACT
ObjectiveaaTo explore whether the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) can be 
used to screen for dementia or mild cognitive impairment (MCI) in less educated patients with Parkinson’s disease (PD).
MethodsaaWe reviewed the medical records of PD patients who had taken the Korean MMSE (K-MMSE), Korean MoCA (K-
MoCA), and comprehensive neuropsychological tests. Predictive values of the K-MMSE and K-MoCA for dementia or MCI 
were analyzed in groups divided by educational level. 
ResultsaaThe discriminative powers of the K-MMSE and K-MoCA were excellent [area under the curve (AUC) 0.86–0.97] for 
detecting dementia but not for detecting MCI (AUC 0.64–0.85). The optimal screening cutoff values of both tests increased with 
educational level for dementia (K-MMSE < 15 for illiterate, < 20 for 0.5–3 years of education, < 23 for 4–6 years, < 25 for 7–9 years, and 
< 26 for 10 years or more; K-MoCA < 7 for illiterate, < 13 for 0.5–3 years, < 16 for 4–6 years, < 19 for 7–9 years, < 20 for 10 years or 
more) and MCI (K-MMSE < 19 for illiterate, < 26 for 0.5–3 years, < 27 for 4–6 years, < 28 for 7–9 years, and < 29 for 10 years or 
more; K-MoCA < 13 for illiterate, < 21 for 0.5–3 years, < 23 for 4–6 years, < 25 for 7–9 years, < 26 for 10 years or more).
ConclusionaaBoth MMSE and MoCA can be used to screen for dementia in patients with PD, regardless of educational level; 
however, neither test is sufficient to discriminate MCI from normal cognition without additional information.
Key WordsaaMini-Mental State Examination; Montreal Cognitive Assessment; Parkinson’s disease; dementia; mild cognitive 
impairment.
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JMD
Cognitive impairment is common in patients with Parkin-
son’s disease (PD), and its prevalence has been reported to be 
up to 80%.1 Recently, diagnostic criteria for dementia or mild 
cognitive impairment (MCI) were proposed by the Movement 
Disorders Society Task Force and are widely used.2,3 The level II 
assessments provide much more diagnostic accuracy and quan-
titative information; however, the detailed neuropsychological 
tests recommended by the level II assessments require consid-
erable time and cost. For these reasons, the guidelines also sug-
gest level I criteria using the following short tests: the Mini-
Mental State Examination (MMSE) for dementia, the Montreal 
Cognitive Assessment (MoCA) or Scales for Outcomes in PD-
Cognition (SCOPA-Cog) for MCI. The MMSE has been widely 
used for diagnosing dementia based on the level I criteria,2 and 
the MoCA has been reported to reflect cognitive status better 
in patients with PD.4-10
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Almost all of the published data for the MMSE 
or the MoCA to evaluate cognitive function in pa-
tients with PD were obtained from well-educated 
subjects; however, a large portion of elderly patients 
of many countries have a low level of education. For 
example, a community-based cohort of Korean el-
derly demonstrated that 44.1% of the cohort popu-
lation aged 60 or more have been educated for 6 or 
fewer years.11 Therefore, additional data are neces-
sary to use the MMSE or MoCA to screen for cog-
nitive impairment in less educated patients with PD.
In this study, we explored whether the Korean 
MMSE (K-MMSE) and Korean MoCA (K-MoCA) 
are possible screening tests for dementia or MCI in 
Korean PD patients with a low level of education. 
MATERIALS & METHODS
Subjects
We reviewed the medical records of patients with 
PD who visited a tertiary referral center. We select-
ed patients who had their cognitive status assessed 
by a comprehensive neuropsychological battery from 
Jan 2014 to Dec 2015. PD was diagnosed according 
to the clinical criteria of the UK PD Brain Bank,12 and 
patients who underwent deep brain stimulation or 
were aged less than 50 or more than 85 were exclud-
ed from the study. To rule out patients with demen-
tia with Lewy bodies, we also excluded patients who 
had visual hallucinations or dementia occurring be-
fore or within 1 year following the onset of parkin-
sonism.13 Patients who showed abnormalities in thy-
roid function test or vitamin B 12 levels; subjects who 
were treated with drugs affecting cognitive status 
such as benzodiazepines or antipsychotics were also 
excluded. Subjects having focal brain lesions or 
white matter hyperintensity corresponding to grade 
2 or 3 of the Fazekas scale on a MRI scan were also 
excluded from this study.14
This study was approved by the Institutional Re-
view Board (IRB) and was exempt from the require-
ment for informed consent by the IRB because of its 
retrospective design.
Neuropsychological assessment
The neuropsychological assessments were ad-
ministered by experienced clinical psychologists. 
All subjects were tested with the K-MMSE and K-
MoCA at the start of the assessment.15,16 Items on 
the tests that required literacy (i.e., reading and writ-
ing items for the K-MMSE and trail-making test 
and phonemic fluency item for the K-MoCA) were 
not examined in illiterate subjects. The neuropsy-
chological battery consisted of 10 tests for 5 cogni-
tive domains: attention (forward digit span17 and 
trail-making test A17), language function (Korean 
version of the Boston Naming Test17 and similarity 
test of Wechsler Adult Intelligence Scale-Fourth Edi-
tion18), visuospatial ability [copying the Rey Com-
plex Figure Test17 and clock copying (CLOX2)19], 
memory (20-minute delayed recall using the Seoul 
Verbal Learning Test17 and Rey Complex Figure 
Test17), and executive function [semantic fluency for 
animal using Controlled Oral Word Association 
Test17 and clock drawing test (CLOX1)19]. Cognitive 
performances were calculated into age- and educa-
tion-adjusted z scores using previously published 
normative data.15,16,18,19 The duration of education 
was considered 0 years for illiterate patients and 0.5 
years for patients who could read and write but had 
not received any formal education. Activities of daily 
living (ADL) were evaluated by Clinical Dementia 
Rating (CDR), and a score of 1 or more on the CDR 
was considered impaired ADL.20
 
Diagnostic criteria for MCI and dementia
Dementia was diagnosed using the level II assess-
ment recommended by the Movement Disorder So-
ciety Task Force with modifications.2 The criteria of 
the present study were as follows: 1) the mean z 
score of 2 tests of each cognitive domain was lower 
than mean–1.5 SD of normative data on at least 2 
domains, and 2) an impairment of daily activity was 
indicated by CDR.
MCI was diagnosed according to the criteria pro-
posed by the Movement Disorder Society Task Force 
(level II category).3 MCI was diagnosed when the 
following criteria were met: 1) performance on at 
least 2 of the 10 tests was lower than mean–1.5 SD 
of normative data, and 2) activity of daily living was 
not impaired. 
Statistical analyses
A one-way analysis of variances and chi-square test 
were used to compare the demographic characteris-
tics among groups. Post-hoc analyses were conduct-
ed using Bonferroni’s method. Logistic regression 
analyses were performed to explore the influence of 
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demographic factors such as age, sex difference, 
and education level on the discriminative power of 
the K-MMSE or K-MoCA. The usefulness of the each 
test was evaluated by the area under the curve (AUC), 
sensitivity, specificity, and positive (PPV) and nega-
tive predictive value (NPV). The optimal screening 
cutoff value was defined as the lowest score that yield-
ed sensitivity and NPV > 80%, and the optimal diag-
nostic cutoff value was defined as the highest score 
that yielded specificity and PPV > 80%, if possible. 
The point with maximal accuracy was found using 
the Youden Index. Statistical analyses were perform-
ed using SPSS Statistics 21 (IBM SPSS Inc., Armonk, 
NY, USA), and p < 0.05 was considered statistically 
significant.
RESULTS
Study subjects and demographic data
A total of 505 patients were collected from medi-
cal records. According to the diagnostic criteria, the 
participants were classified into 3 groups: normal 
cognition (n = 255), MCI (n = 161), and dementia (n 
= 78). Eleven patients who reported impaired ADL 
but showed cognitive deficits in only one domain 
were excluded from this study. 
The demographic data of the subjects are present-
ed in Table 1. Compared with non-demented pa-
tients, the patients with dementia aged more, suf-
fered longer with PD, and had more severe motor 
symptoms. The patients with normal cognition were 
significantly more educated than were those with 
MCI.
Cognitive performances of the subjects
Performances on the K-MMSE, K-MoCA, and neu-
ropsychological subtests of groups are presented in 
Table 2. The cognitive performances showed a ten-
dency to decline according to the cognitive deterio-
ration on almost all of the subanalyses.
Demographic factors influencing the  
K-MMSE or K-MoCA score
The results of the logistic regression analyses are 
presented in Table 3. Duration of education influ-
enced the predictive value of the MMSE and K-Mo-
CA to diagnose MCI or dementia consistently. Age 
was a confounding factor in the analysis for the 
MoCA and MCI; however, age did not affect the oth-
er analyses. Sex differences also did not affect the 
prediction of cognitive levels. 
K-MMSE and K-MoCA for screening 
dementia
The discriminative values of the K-MMSE and K-
MoCA to distinguish dementia from MCI or nor-
mal cognition are presented in Table 4. The AUC 
values were higher than 0.9 for the K-MMSE and 
K-MoCA in all education levels except for illiterate 
patients. For the K-MMSE, the optimal screening 
cutoff was < 15 for illiterate patients (AUC 0.86, sen-
sitivity 0.80, specificity 0.82), < 20 for those educat-
ed for 0.5–3 years (AUC 0.95, sensitivity 0.86, spec-
ificity 0.85), < 23 for 4–6 years of education (AUC 
0.92, sensitivity 0.84, specificity 0.84), < 25 for 7–9 
years of education (AUC 0.95, sensitivity 0.90, spec-
ificity 0.85), and < 26 for 10 or more years of educa-
tion (AUC 0.97, sensitivity 0.97, specificity 0.85). For 
the K-MoCA, the optical screening cutoff was < 7 
for illiterate patients (AUC 0.86, sensitivity 0.80, 
specificity 0.77), < 13 for those educated for 0.5–3 
years (AUC 0.93, sensitivity 0.86, specificity 0.88), < 
16 for 4–6 years of education (AUC 0.91, sensitivity 
0.84, specificity 0.89), < 19 for 7–9 years of education 
Table 1. Demographic data of the subjects
PD-N
(n = 255)
PD-MCI
(n = 161)
PD-D
(n = 78)
p value Group comparison‡
Male/female, n 145/110 92/69 42/36 0.88* PD-N = PD-MCI = PD-D
Age, yr 69.3 ± 7.5 70.5 ± 7.3 74.2 ± 6.3 < 0.001† PD-N = PD-MCI < PD-D
Education, yr 9.3 ± 4.7 7.7 ± 5.4 8.3 ± 5.5 0.004† PD-N > PD-MCI
Duration of PD, yr 3.6 ± 3.5 4.8 ± 4.5 6.7 ± 4.5 < 0.001† PD-N = PD-MCI < PD-D
UPDRS motor score 23.7 ± 11.6 24.6 ± 11.9 32.3 ± 10.0 0.006† PD-N = PD-MCI < PD-D
Hoehn & Yahr stage 1.9 ± 0.6 2.1 ± 0.6 2.7 ± 0.7 0.003† PD-N = PD-MCI < PD-D
LED, mg/day 208 ± 363 430 ± 479 602 ± 352 0.027† PD-N < PD-D
BDI score 14.1 ± 9.9 12.2 ± 9.0 18.1 ± 11.9 0.19† PD-N = PD-MCI = PD-D
Data are expressed as the mean ± SD. *chi-square test, †ANOVA, ‡by Bonferroni’s method. PD: Parkinson’s disease, PD-N: Parkin-
son’s disease with normal cognition, PD-MCI: Parkinson’s disease with mild cognitive impairment, PD-D: Parkinson’s disease with 
dementia, UPDRS: Unified Parkinson’s Disease Rating Scale, LED: levodopa equivalent dose, BDI: Beck’s Depression Inventory.
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(AUC 0.92, sensitivity 0.90, specificity 0.83), and < 
20 for 10 or more years of education (AUC 0.96, sen-
sitivity 0.83, specificity 0.92). 
K-MMSE and K-MoCA for screening MCI
The discriminative values of the K-MMSE and K-
MoCA to distinguish MCI from normal cognition 
were calculated after excluding patients with demen-
tia from the data (Table 5). The AUC varied between 
0.64 and 0.85 for the K-MMSE and between 0.70 
and 0.83 for the K-MoCA throughout all education 
levels. In the case of the K-MMSE, the optimal sc-
reening cutoff was < 19 for illiterate patients (AUC 
0.85, sensitivity 0.86, specificity 0.75), < 26 for those 
educated for 0.5–3 years (AUC 0.83, sensitivity 0.87, 
specificity 0.61), < 27 for 4–6 years of education 
Table 2. Cognitive performances according to the cognitive level and duration of education
Years of education
PD-N
(n = 255)
PD-MCI
(n = 161)
PD-D
(n = 78)
p value Group comparison
MMSE 27.0 ± 2.5 23.9 ± 4.0 18.5 ± 4.5 < 0.001 PD-N > PD-MCI > PD-D
Illiteracy 20.3 ± 3.7 15.5 ± 2.9 12.8 ± 2.4 0.001 PD-N > PD-MCI = PD-D
0.5–3 25.6 ± 2.5 21.8 ± 3.2 15.6 ± 3.3 < 0.001 PD-N > PD-MCI > PD-D
4–6 26.5 ± 2.3 24.1 ± 2.5 18.4 ± 4.6 < 0.001 PD-N > PD-MCI > PD-D
7–9 26.9 ± 2.1 25.4 ± 2.7 20.6 ± 2.9 < 0.001 PD-N > PD-MCI > PD-D
≥ 10 28.1 ± 1.4 26.3 ± 2.0 20.1 ± 4.3 < 0.001 PD-N > PD-MCI > PD-D
MoCA 23.2 ± 4.4 18.6 ± 5.4 12.1 ± 5.2 < 0.001 PD-N > PD-MCI > PD-D
Illiteracy 12.1 ± 1.9 8.4 ± 3.8 5.0 ± 2.3 0.002 PD-N > PD-MCI > PD-D
0.5–3 20.1 ± 4.0 14.9 ± 3.7 9.1 ± 3.8 < 0.001 PD-N > PD-MCI > PD-D
4–6 21.5 ± 4.3 18.5 ± 3.5 11.9 ± 4.9 < 0.001 PD-N > PD-MCI > PD-D
7–9 23.0 ± 3.1 19.9 ± 3.7 13.9 ± 4.4 < 0.001 PD-N > PD-MCI > PD-D
≥ 10 25.6 ± 3.0 22.5 ± 3.2 14.2 ± 4.9 < 0.001 PD-N > PD-MCI > PD-D
Attention domain* 0.23 ± 0.94 -0.26 ± 0.88 -0.75 ± 0.88 < 0.001 PD-N > PD-MCI > PD-D
Illiteracy -0.02 ± 0.61 -0.30 ± 0.57 -0.66 ± 0.63 0.222 PD-N = PD-MCI = PD-D
0.5–3 0.25 ± 1.28 -0.30 ± 0.92 -0.71 ± 0.66 0.030 PD-N > PD-D
4–6 0.10 ± 0.75 -0.18 ± 0.86 -0.53 ± 0.79 0.025 PD-N > PD-D
7–9 0.17 ± 0.67 -0.36 ± 0.85 -0.53 ± 0.49 0.001 PD-N > PD-MCI = PD-D
≥ 10 0.55 ± 0.72 -0.12 ± 0.61 -0.81 ± 0.74 < 0.001 PD-N > PD-MCI > PD-D
Language function* 0.17 ± 0.71 -0.87 ± 0.77 -1.70 ± 1.03 < 0.001 PD-N > PD-MCI > PD-D
Illiteracy -0.31 ± 0.90 -0.84 ± 0.64 -1.79 ± 0.53 0.01 PD-N > PD-D
0.5–3 -0.18 ± 0.72 -1.28 ± 0.82 -1.84 ± 0.78 < 0.001 PD-N > PD-MCI = PD-D
4–6 -0.03 ± 0.54 -0.88 ± 0.73 -1.67 ± 1.00 < 0.001 PD-N > PD-MCI > PD-D
7–9 0.18 ± 0.66 -0.86 ± 0.75 -0.81 ± 0.90 < 0.001 PD-N > PD-MCI = PD-D
≥ 10 0.35 ± 0.72 -0.65 ± 0.74 -1.90 ± 1.13 < 0.001 PD-N > PD-MCI > PD-D
Visuospatial function* 0.12 ± 0.78 -1.37 ± 1.69 -3.72 ± 2.84 < 0.001 PD-N > PD-MCI > PD-D
Illiteracy -0.39 ± 0.55 -0.81 ± 1.00 -1.91 ± 1.07 0.035 PD-N > PD-D
0.5–3 -0.08 ± 0.92 -1.73 ± 0.96 -2.31 ± 1.48 < 0.001 PD-N > PD-MCI = PD-D
4–6 0.11 ± 0.79 -1.35 ± 1.50 -2.84 ± 1.62 < 0.001 PD-N > PD-MCI > PD-D
7–9 0.21 ± 0.74 -1.00 ± 2.01 -3.42 ± 2.64 < 0.001 PD-N > PD-MCI > PD-D
≥ 10 0.16 ± 0.77 -1.46 ± 2.00 -4.88 ± 3.41 < 0.001 PD-N > PD-MCI > PD-D
Memory* -0.03 ± 0.76 -1.07 ± 0.77 -1.76 ± 0.61 < 0.001 PD-N > PD-MCI > PD-D
Illiteracy -0.48 ± 0.54 -0.57 ± 0.70 -0.84 ± 0.13 0.6 PD-N = PD-MCI = PD-D
0.5–3 -0.23 ± 0.92 -0.87 ± 0.68 -1.36 ± 0.51 < 0.001 PD-N > PD-MCI = PD-D
4–6 0.13 ± 0.72 -0.88 ± 0.88 -1.61 ± 0.38 < 0.001 PD-N > PD-MCI > PD-D
7–9 -0.13 ± 0.78 -1.33 ± 0.64 -1.65 ± 0.41 < 0.001 PD-N > PD-MCI = PD-D
≥ 10 -0.07 ± 0.72 -1.28 ± 0.69 -2.13 ± 0.56 < 0.001 PD-N > PD-MCI > PD-D
Executive function* 0.02 ± 1.04 -0.66 ± 0.95 -1.73 ± 0.83 < 0.001 PD-N > PD-MCI > PD-D
Illiteracy 0.07 ± 0.92 -0.87 ± 0.88 -2.30 ± 0.34 0.001 PD-N = PD-MCI > PD-D
0.5–3 0.48 ± 1.31 -0.48 ± 1.01 -1.07 ± 0.76 < 0.001 PD-N > PD-MCI = PD-D
4–6 -0.22 ± 1.14 -0.65 ± 1.13 -1.55 ± 0.97 0.001 PD-N = PD-MCI > PD-D
7–9 -0.04 ± 0.93 -0.63 ± 0.87 -1.41 ± 0.74 < 0.001 PD-N > PD-MCI = PD-D
≥ 10 0.04 ± 0.97 -0.70 ± 0.86 -2.05 ± 0.65 < 0.001 PD-N > PD-MCI > PD-D
*z score. PD-N: Parkinson’s disease with normal cognition, PD-MCI: Parkinson’s disease with mild cognitive impairment, PD-D: 
Parkinson’s disease with dementia, MMSE: Mini-Mental State Examination, MoCA: Montreal Cognitive Assessment.
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(AUC 0.76, sensitivity 0.86, specificity 0.55), < 28 for 
7–9 years of education (AUC 0.64, sensitivity 0.84, 
specificity 0.39), and < 29 for 10 or more years of ed-
ucation (AUC 0.77, sensitivity 0.88, specificity 0.44). 
For the K-MoCA, the optical screening cutoff was 
< 13 for illiterate patients (AUC 0.81, sensitivity 0.93, 
specificity 0.38), < 21 for those educated for 0.5–3 
years (AUC 0.83, sensitivity 0.93, specificity 0.43), < 
23 for 4–6 years of education (AUC 0.70, sensitivity 
0.89, specificity 0.43), < 25 for 7–9 years of education 
(AUC 0.74, sensitivity 0.88, specificity 0.34), and < 
26 for 10 or more years of education (AUC 0.77, sen-
sitivity 0.84, specificity 0.60). 
DISCUSSION
The present study is the first to evaluate the dis-
criminative value of the MMSE and MoCA in less 
educated patients with PD. The results demonstrated 
the excellent discriminative power of the K-MMSE 
and K-MoCA in screening for dementia, regardless 
of education level. Both tests could be useful but are 
insufficient to distinguish MCI from normal cogni-
tion.
Although the age, sex difference, and level of ed-
ucation were reported as factors influencing the nor-
mative value for the K-MMSE or K-MoCA,16,21 the 
logistic regression analyses showed that the dura-
tion of education was the only factor associated with 
the score on both tests. Age influenced the K-MoCA 
score in the analysis for predicting MCI alone, but 
sex did not affect the association. This result was in 
agreement with previously reported normative data 
that also showed the strongest effect of education 
level on the K-MMSE and K-MoCA scores.16,21 Th-
erefore, in the present study, the discriminative val-
ues were calculated for each group divided by the 
educational level.
In the group of highly educated patients (≥ 10 
years), the cutoff values for detecting dementia or 
MCI were similar to those of previous reports. For 
dementia, the cutoff scores of the present study were 
MMSE < 26 and MoCA < 20. A New Zealand group 
reported cutoff scores of MMSE < 26 (AUC 0.91, 
sensitivity 0.86, specificity 0.75) and MoCA < 21 
(AUC 0.97, sensitivity 0.81, specificity 0.95),4 and a 
study in Greek patients suggested a MoCA score < 
21 (sensitivity 0.82, specificity 0.90) as an optimal 
cutoff.22 In contrast, an American research group 
reported a much higher screening cutoff value for 
detecting dementia: MMSE < 29 and MoCA < 25.5 
This gap might be due to an extremely high level of 
education (mean 16 years), differences in group 
comparisons (dementia vs. normal cognition with-
Table 3. Multivariate logistic regression models to predict the cognitive level in patients with Parkinson’s disease
Variables Odds ratio 95% CI p value
MMSE
MCI (Hosmer-Lemeshow test, χ2 = 7.28, p = 0.51)
MMSE 0.67 0.60–0.74 < 0.001
Education 1.06 1.00–1.12 0.04
Age 0.98 0.95–1.01 0.2
Female sex 0.82 0.50–1.36 0.4
Dementia (Hosmer-Lemeshow test, χ2 = 9.34, p = 0.31)
MMSE 0.55 0.49–0.63 < 0.001
Education 1.32 1.19–1.45 < 0.001
Age 0.99 0.94–1.05 0.8
Female sex 1.07 0.49–2.36 0.9
MoCA
MCI (Hosmer-Lemeshow test, χ2 = 7.61, p = 0.47)
MoCA 0.74 0.69–0.80 < 0.001
Education 1.12 1.05–1.19 0.001
Age 0.97 0.93–1.00 0.03
Female sex 0.82 0.49–1.35 0.4
Dementia (Hosmer-Lemeshow test, χ2 = 4.84, p = 0.78)
MoCA 0.62 0.56–0.69 < 0.001
Education 1.35 1.22–1.49  < 0.001
Age 0.98 0.93–1.04 0.6
Female sex 0.92 0.41–2.09 0.8
CI: confidence interval, MMSE: Mini-Mental State Examination, MCI: mild cognitive impairment, MoCA: Montreal Cognitive Assessment.
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out MCI), and different diagnostic criteria for de-
mentia. For MCI, the optimal screening cutoff val-
ues of the present study (MMSE < 29 and MoCA < 
26) were identical or similar to those of previous 
reports (MMSE < 29 and MoCA < 26;4 MMSE < 30 
and MoCA < 27;5 MMSE < 30 and MoCA < 27;8 
MoCA < 279). These studies were conducted with 
different diagnostic criteria for PD-MCI; therefore, 
future work should determine whether these differ-
ences influence the cutoff values of MMSE or MoCA.
Both the K-MMSE and K-MoCA showed excel-
lent discriminative power to predict dementia, re-
gardless of educational level. In the illiterate group, 
the MoCA is not recommended, although the dis-
criminative power of the K-MoCA for dementia 
was good (AUC 0.86) and was similar to that of the 
K-MMSE. Although two items of each test were not 
examined in illiterate patients, the remaining 28 
points on both tests appeared to be sufficient for 
screening for dementia. 
For screening MCI, the K-MMSE and K-MoCA 
showed good to fair discriminative powers, except 
for the analysis of K-MMSE and 7–9 years of educa-
tion. Both tests were comparable in detection abili-
ty but were not sufficient for the excellent prediction 
of MCI. This suboptimal specificity was also ob-
served in early publications. Hoops et al.5 reported 
that the tests were not excellent for the prediction 
of MCI (AUC: MMSE 0.72, MoCA 0.74). Chou et 
al.7 also suggested that the MoCA has limited diag-
nostic accuracy for PD-MCI (sensitivity 0.59, spec-
ificity 0.69). However, Dalrymple-Alford et al.4 sh-
owed superior discriminative power of the MoCA 
(AUC 0.90) for MCI compared with the MMSE 
(AUC 0.78), and Gill et al.8 reported that both tests 
have good power (AUC: MMSE 0.90, MoCA 0.85). 
As in variable cutoff values for MMSE and MoCA, 
there are many factors affecting this result, such as 
the level of education, diagnostic criteria of study 
subjects, and other factors; therefore, more data are 
required to address this disagreement. 
This study had several limitations. Although this 
study included the largest number of subjects, the 
sample sizes of each educational group were small. 
Second, there could be some error regarding the 
data of educational level because these data were 
collected based on patients’ or caregivers’ reports. 
Third, there is no consensus on the cutoff value 
(1–2 SD) of each test for diagnosing MCI in patients 
with PD. We used 1.5 SD in this study, although 1 
or 2 SD was used in other studies. 
This study showed that the MMSE and MoCA 
could be useful tools for screening for dementia in 
patients with PD, regardless of educational level. 
However, the tests are not sufficient to discriminate 
MCI from normal cognition without additional in-
formation. 
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